...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of a New Device for Simplifying and Standardizing Stool Sample Preparation for Viral Molecular Testing with Limited Hands-On Time
【24h】

Evaluation of a New Device for Simplifying and Standardizing Stool Sample Preparation for Viral Molecular Testing with Limited Hands-On Time

机译:在有限的动手时间下简化和标准化用于病毒分子测试的粪便样品制备新设备的评估

获取原文

摘要

Sensitive molecular assays have greatly improved the diagnosis of viral gastroenteritis. However, the proper preparation of stool samples for clinical testing remains an issue. bioMérieux has developed a stool preprocessing device (SPD) that includes a spoon for calibrated sampling and a vial containing buffer, glass beads, and two filters. The resulting stool filtrate is used for nucleic acid extraction. The purpose of this study was to evaluate the performance of the SPD for the quantification of human adenovirus (HAdV) DNA in stool samples collected from hematopoietic stem cell transplant (HSCT) recipients. HAdV DNA was quantified with the Adenovirus R-gene kit. The suitability of the device to reproducibly quantify HAdV DNA in stools using different extraction platforms (easyMAG and QIAsymphony) was determined using archived HAdV-positive stool samples. Coefficients of variation of HAdV DNA quantifications ranged from 1.79% to 1.83%, and no difference in quantification was observed between the two extraction systems. The HAdV DNA limit of quantification using the SPD was 3.75 log10 copies/g of stool. HAdV DNA quantification using the SPD was then compared to that of the routine preprocessing technique on 75 fresh stool samples collected prospectively from pediatric HSCT recipients at risk for HAdV infections. Thirty-eight samples were HAdV DNA positive with both the SPD and routine preprocessing methods. HAdV DNA loads were on average 1.14-log10 copies/g of stool higher with the SPD (P < 0.0001) than with routine methods. This new device enabled a standardized preparation of stool samples in <5 min and a reproducible and sensitive quantification of HAdV DNA. The use of the SPD for the detection of other gastrointestinal infections warrants further evaluation.
机译:灵敏的分子测定极大地改善了病毒性胃肠炎的诊断。但是,为临床测试正确准备粪便样品仍然是一个问题。 bioMérieux开发了一种粪便预处理设备(SPD),该设备包括一个用于校准采样的勺子和一个装有缓冲液,玻璃珠和两个过滤器的小瓶。所得粪便滤液用于核酸提取。这项研究的目的是评估SPD在定量从造血干细胞移植(HSCT)受者收集的粪便中提取人腺病毒(HAdV)DNA的性能。用腺病毒R基因试剂盒定量HAdV DNA。使用存档的HAdV阳性粪便样品确定该设备使用不同的提取平台(easyMAG和QIAsymphony)可重复地定量粪便中HAdV DNA的适用性。 HAdV DNA定量的变异系数范围为1.79%至1.83%,并且在两个提取系统之间未观察到定量差异。使用SPD定量的HAdV DNA限度为3.75 log 10 拷贝/ g粪便。然后将使用SPD进行的HAdV DNA定量与常规预处理技术的定量进行了比较,前者是从有HAdV感染风险的儿科HSCT接受者中收集的75个新鲜粪便样品。采用SPD和常规预处理方法的38份样品均为HAdV DNA阳性。 SPd( P <0.0001)的HAdV DNA载量平均比粪便高1.14-log 10 / g粪便( P <0.0001)。这款新设备可在不到5分钟的时间内对粪便样品进行标准化制备,并对HAdV DNA进行可重复且灵敏的定量。 SPD用于检测其他胃肠道感染的情况值得进一步评估。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号